Resources & Publications

Recent Publications
& Clinical Research

Discover the latest research and insights in artificial intelligence and systems pathology from PreciseDx®.

Press Release Publication Infographic Media Coverage Media Alert Poster
08/21/2024 | Media Coverage | BioSpace
PreciseDx Secures $20.7 Million Series B to Advance AI-Powered Cancer Risk Assessments
Read More
08/21/2024 | Media Coverage | Precision Medicine Online
PreciseDx Raises $20.7M in Series B Round
Read More
08/21/2024 | Press Release | prnewswire
PreciseDx Secures $20.7 Million Series B to Advance AI-Powered Cancer Risk Assessments
Read More
08/02/2024 | Media Coverage | 360Dx
As AI-Based Diagnostics Proliferate, Stakeholders Strive for Regulation Without Stifling Innovation
Read More
07/31/2024 | Media Coverage | Medtech Insight
News We’re Watching: FDA Warning Letters; First Hysterectomy With MIRA Robot; DOJ Finalizes Rule On Accessibility; And More
Read More
07/23/2024 | Press Release
PreciseDx Announces Publication of Its Cost Impact Study, Payer Impact of PreciseBreast™(PDxBr) to Identify Breast Cancer Recurrence, in the Journal Of Medical Economics
Read More
07/09/2024 | Publication | Journal of Medical Economics
U.S. Payer Budget Impact of Using an AI-Augmented Cancer Risk Discrimination Digital Histopathology Platform to Identify High-Risk of Recurrence in Women with Early-Stage Invasive Breast Cancer
Read More
06/03/2024 | Poster
ASCO-24: AI-Enabled Digital Test to Predict Disease Recurrence for Patients with Early-Stage Invasive Breast Cancer Demonstrates Good Performance in a MammaPrint Low-risk Cohort from the Netherlands with a Median 6-year Follow-Up
Read More
05/31/2024 | Media Coverage
COTA, Baptist Health South Florida, PreciseDx collaborate on AI-based test for IBC recurrence
Read More
05/31/2024 | Media Coverage
360Dx Newsletter: Cota, PreciseDx, Baptist Health South Florida to Assess Invasive Breast Cancer Recurrence Test
Read More